Diphenyl diselenide improves scopolamine-induced memory impairment in mice

Behavioural Pharmacology

Volumn 21, Issue 5-6, 2010, Pages 556-562

  Souza, Ana Cristina G ^a   Brüning, César Augusto ^a   Leite, Marlon Régis ^a   Zeni, Gilson ^a   Nogueira, Cristina Wayne ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Memory; Morris water maze test; mouse; scopolamine; selenium; Y maze test

Indexed keywords

DIPHENYL DISELENIDE; SCOPOLAMINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; ESCAPE BEHAVIOR; LATENT PERIOD; LOCOMOTION; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PERFORMANCE; SHORT TERM MEMORY; TIME;

ALZHEIMER DISEASE; ANIMALS; BENZENE DERIVATIVES; DISEASE MODELS, ANIMAL; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; ORGANOSELENIUM COMPOUNDS; SCOPOLAMINE; TIME FACTORS;

EID: 77955984629     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32833befcf     Document Type: Article

References (39)

1. Acker CI, Luchese C, Prigol M, Nogueira CW (2009). Antidepressant-like effect of diphenyl diselenide on rats exposed to malathion: involvement of Na+K+ATPase activity. Neurosci Lett 455:168-172.
2. Barnes CA, Danysz W, Parsons CG (1996). Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal longterm potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats. Eur J Neurosci 8:565-571.
3. Bartus RT (2000). On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163:495-529.
4. Blokland A (1995). Acetylcholine: a neurotransmitter for learning and memory? Brain Res Rev 21:285-300.
5. Blokland A, Geraerts E, Been M (2004). A detailed analysis of rats' spatial memory in a probe trial of a Morris task. Behav Brain Res 154:71-75.
6. Brüning CA, Prigol M, Nogueira CW, Zeni G, Roehrs JA (2009). Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyl-diphenyl diselenide in mice. Behav Brain Res 205:511-517.
7. Chen J, Berry MJ (2003). Selenium and selenoproteins in the brain and brain diseases. J Neurochem 86:1-12.
8. Cummings JL, Kaufer D (1996). Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 47:876-883.
9. Ebert U, Kirch W (1998). Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 28:944-949.
10. Francis PT, Palmer AM, Snape M,Wilcock GK (1999). The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137-147.
11. Giacobini E (1996). New trends in cholinergic therapy for Alzheimer's disease: nicotin agonists or cholinesterases inhibitors? Prog Brain Res 109:311-323.
12. Hughes RN (2004). The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev 28:497-505.
13. Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, et al. (2009). Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 1281:117-127.
14. Kopelman MD, Corn TH (1988). Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome. Brain 111:1079-1110.
15. Machado MS, Rosa RM, Dantas AS, Reolon GK, Appelt HR, Braga AL, et al. (2006). An organic selenium compound attenuates apomorphine-induced stereotypy in mice. Neurosci Lett 410:198-202.
16. Maurice T, Hiramatsu M, Itoh J, Kameyama T, Hasegawa T, Nabeshima T (1994). Behavioral evidence for a modulating role of s ligands in memory processes. 1. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 647:44-56.
17. Mazzanti CM, Spanevello R, Ahmed M, Pereira L, Gonçalves JF, Corrêa M (2009). Pre-treatment with ebselen and vitamin E modulate acetylcholinesterase activity: interaction with demyelinating agents. Int J Devl Neuroscience 27:73-80.
18. Meotti FC, Stangherlin E, Zeni G, Nogueira CW, Rocha JBT (2004). Protective role of aryl and alkyl diselenide on lipid peroxidation. Environ Res 94:276-282.
19. Morris RG (1984). Development of a water maze procedure for studying spatial learning in the rat. J Neurosci Meth 11:47-60.
20. Nève J (1991). Methods in determination of selenium status. J Trace Elem Electrolytes Health Dis 5:1-17.
21. Nogueira CW, Quinhones EB, Jung EAC, Zeni G, Rocha JBT (2003). Antiinflammatory and antinociceptive activity of diphenyl diselenide. Inflamm Res 52:56-63.
22. Nogueira CW, Zeni G, Rocha JBT (2004). Organosellenium and organotellurium compounds: pharmacology and toxicology. Chem Rev 104:6255-6286.
23. Ögren SO, Kehr J, Schött PA (1996). Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat. Neuroscience 75:1127-1140.
24. Ostadalova I, Vobechy M, Chvojkova Z, Mikova D, Hampl V, Wilhelm J, Ostadal B (2007). Selenium protects the immature rat heart against ischemia/reperfusion injury. Mol Cell Biochem 300:259-267.
25. Paulmier C (1986). Selenoorganic functional groups. In: Paulmier C, editor. Selenium reagents and intermediates in organic synthesis. 1st ed. England: Pergamon Press, Oxford. pp, 25-51.
26. Porciúncula LO, Rocha JBT, Boeck CR, Vendite D, Souza DO (2001). Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons. Neurosci Lett 299:217-220.
27. Posser T, Franco JL, Dos Santos DA, Rigon AP, Farina M, Rocha JBT, et al. (2008). Diphenyl diselenide confers neuroprotection against hydrogen peroxide toxicity in hippocampal slices. Brain Res 1199:138-147.
28. Prigol M, Schumacher RF, Nogueira CW, Zeni G (2009). Convulsant effect of diphenyl diselenide in rats and mice and its relationship to plasma levels. Toxicol Lett 189:35-39.
29. Qin F, Ye Y, Yao X (2008). Effects of nano-selenium on the capability of learning memory and the activity of Se-protein of mice. Wei Sheng Yan Jiu 37:502-504.
30. Rayman MP (2000). The importance of selenium to human health. Lancet 356:233-241.
31. Rosa RM, Flores DG, Appelt HR, Braga AL, Henriques JAP, Roesler R (2003). Facilitation of long-term object recognition memory by pretraining administration of diphenyl diselenide in mice. Neurosci Lett 341:217-220.
32. Sarter M, Bodewitz G, Stephens DN (1988). Attenuation of scopolamine induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and b-carboline. Psychopharmacology 94:491-495.
33. Satyanarayana S, Sekhar JR, Kumar KE, Shannika LB, Rajanna B, Rajanna S (2006). Influence of selenium (antioxidant) on gliclazide induced hypogly-caemia/anti hyperglycaemia in normal/alloxan-induced diabetic rats. Mol Cell Biochem 283:123-127.
34. Savegnago L, Pinto LG, Jesse CR, Alves D, Rocha JBT, Nogueira CW, et al. (2007). Antinociceptive properties of diphenyl diselenide: evidences for the mechanism of action. Eur J Pharmacol 555:129-138.
35. Savegnago L, Jesse CR, Pinto LG, Rocha JBT, Barancelli DA, Nogueira CW, Zeni G (2008). Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action. Pharmacol Biochem Behav 88:418-426.
36. Schweizer U, Bräuer AU, Köhrle J, Nitsch R, Savaskan NE (2004). Selenium and brain function: a poorly recognized liaison. Brain Res Rev 45:164-178.
37. Stangherlin EC, Luchese C, Pinton S, Rocha JBT, Nogueira CW (2008). Sub-chronical exposure to diphenyl diselenide enhances acquisition and retention of spatial memory in rats. Brain Res 1201:106-113.
38. Walsh RN, Cummins RA (1976). The open-field test: a critical review. Psychol Bull 83:482-504.
39. Wesnes KA, Simpson PM, White L, Pinker S, Jertz G, Murphy M, Siegfried K (1991). Cholinesterase inhibition in the scopolamine model of dementia. Ann NY Acad Sci 640:268-271.